Literature DB >> 19765368

Evolving concepts in Clostridium difficile colitis.

Naomi G Diggs1, Christina M Surawicz.   

Abstract

Clostridium difficile infection (CDI) is the most important cause of nosocomial diarrhea. The emergence of a hypervirulent strain and other factors including antibiotic overuse contribute to the increasing incidence and severity of this potentially lethal infection. CDI has been reported in persons previously considered as low risk, such as young healthy persons without exposure to health care settings or antibiotics, peripartum women, and children. In patients with inflammatory bowel disease, the risk of C. difficile infection is even greater, with higher rates of hospitalization, bowel surgery, and mortality. With increasing incidence and severity of disease, the need for improved diagnostic, treatment, and infection control strategies cannot be overstated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765368     DOI: 10.1007/s11894-009-0060-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  48 in total

Review 1.  Recurrent clostridium difficile.

Authors:  Seema Maroo; J Thomas Lamont
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

2.  Incidence of Clostridium difficile infection in inflammatory bowel disease.

Authors:  Joseph F Rodemann; Erik R Dubberke; Kimberly A Reske; Da Hea Seo; Christian D Stone
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

3.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

Review 4.  Clinical review of the management of fulminant clostridium difficile infection.

Authors:  M Raffat Jaber; Snorri Olafsson; Wesley L Fung; Mark E Reeves
Journal:  Am J Gastroenterol       Date:  2008-10-01       Impact factor: 10.864

5.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

Authors:  L V McFarland; C M Surawicz; R N Greenberg; R Fekety; G W Elmer; K A Moyer; S A Melcher; K E Bowen; J L Cox; Z Noorani
Journal:  JAMA       Date:  1994 Jun 22-29       Impact factor: 56.272

6.  Rapid and reliable diagnostic algorithm for detection of Clostridium difficile.

Authors:  Lukas Fenner; Andreas F Widmer; Gisela Goy; Sonja Rudin; Reno Frei
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

7.  Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

Authors:  Barbara Geric; Robert J Carman; Maja Rupnik; Christopher W Genheimer; Susan P Sambol; David M Lyerly; Dale N Gerding; Stuart Johnson
Journal:  J Infect Dis       Date:  2006-03-06       Impact factor: 5.226

8.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; E L McGinley; D G Binion
Journal:  Gut       Date:  2007-09-28       Impact factor: 23.059

9.  Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease.

Authors:  S B Debast; E van Kregten; K M G Oskam; T van den Berg; R J Van den Berg; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2008-04-03       Impact factor: 8.067

10.  Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial.

Authors:  Marlene Wullt; Marie-Louise Johansson Hagslätt; Inga Odenholt
Journal:  Scand J Infect Dis       Date:  2003
View more
  4 in total

Review 1.  Clostridium difficile infection: epidemiology, risk factors and management.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

2.  Genetic risk factors for Clostridium difficile infection in ulcerative colitis.

Authors:  A N Ananthakrishnan; E C Oxford; D D Nguyen; J Sauk; V Yajnik; R J Xavier
Journal:  Aliment Pharmacol Ther       Date:  2013-07-14       Impact factor: 8.171

Review 3.  Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  Lisa Saidel-Odes; Abraham Borer; Selwyn Odes
Journal:  Ann Gastroenterol       Date:  2011

4.  Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study.

Authors:  Young Seok Doh; You Sun Kim; Hye Jin Jung; Young Il Park; Jin Won Mo; Hyun Sung; Kyung Jin Lee; Young Ki Seo; Jeong Seop Moon; Seong Woo Hong
Journal:  Intest Res       Date:  2014-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.